Visudyne

Visudyne (verteporfin) is an intravenous medication used in photodynamic therapy for certain eye conditions. It works with laser light to target abnormal blood vessels. This EU-sourced treatment is administered under medical supervision for specific retinal disorders.

Visudyne is primarily used to treat eye conditions involving abnormal blood vessel growth, such as wet age-related macular degeneration. It may also be used for other retinal disorders where abnormal vessels cause vision problems. The medication is part of a therapy that combines drug and light to target affected areas.

After administration, Visudyne circulates in the bloodstream and accumulates in abnormal blood vessels in the eye. When activated by a specific laser light, it helps close off these vessels, reducing leakage and swelling. Patients may notice improved vision clarity over time as the treatment takes effect.

Visudyne should only be handled and administered by healthcare professionals in a controlled setting. Patients must avoid direct sunlight or bright indoor light for several days after treatment to prevent skin reactions. Protective measures, such as wearing dark sunglasses and protective clothing, are recommended during this period.

Visudyne may interact with other medications that increase sensitivity to light, such as certain antibiotics or diuretics. Combining it with these drugs could heighten the risk of skin reactions. Patients should inform their healthcare provider about all medications they are taking before receiving Visudyne.